Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve With reference to the above captioned subject matter, we hereby inform you that the Meeting of Board of Directors of the Company will be held on Saturday, May 30, 2026 at 04:00 PM at the Corporate Office of the Company, inter-alia, to consider the following matters: \r\n\r\n1. Consider and adopt the Audited Financial Statements (Standalone and Consolidated) for the quarter and year ended March 31, 2026; \r\n2. Consider the Independent Reports' of the Statutory Auditor on Standalone and Consolidated Financial Statements for the quarter and year ended March 31, 2026; \r\n3. Other Business items. \r\n\r\nFurther, in continuation to earlier disclosure dated March 25, 2026, Trading Window for dealing in the securities of the Company shall open after 48 hours of declaration of Audited Financial Results for all designated persons, their immediate relatives and all connected persons covered under the aforesaid code.\r\n\r\nThis intimation is also being uploaded on the Company website: www.gennexlab.com.\r\n\r\n\r\n